Advertisement
Screener

GENZYME CORP Patents: Applications Pending, 2021

GENZYME CORP Patent Applications Pending

36 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2021-12-22: Application PCTUS2021064831; Invention DEUTERATED COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS; Applicant GENZYME CORPORATION; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2021-12-22: Application PCTUS2021064800; Invention 4-AMINO-3-(4-PHENOXYPHENYL)-1,3-DIHYDRO-2HIMIDAZO[4,5-C]PYRIDIN-2-ONE DERIVATIVES AND SALTS THEREOF; Applicant GENZYME CORPORATION; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2021-12-22: Application 63293070; Invention METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA; Applicant Genzyme Corporation; Status Provisional Application Expired.
  • 2021-12-21: Application 63292124; Invention CRYSTALLINE FORMS OF (R)-1-(1-ACRYLOYLPIPERIDIN-3-YL)-4-AMINO-3-(4-PHENOXYPHENYL)-1H-IMIDAZO[4,5-C]PYRIDIN-2(3H)-ONE AND DERIVATIVES THEREOF; Applicant Genzyme Corporation; Status Provisional Application Expired.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2021-12-22PCTUS2021064831DEUTERATED COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORSGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
JOHN L. KANE, JR
MARIA A. FITZGERALD
NELLWYN A. HAGAN
United States
United States
United States
2021-12-22PCTUS20210648004-AMINO-3-(4-PHENOXYPHENYL)-1,3-DIHYDRO-2HIMIDAZO[4,5-C]PYRIDIN-2-ONE DERIVATIVES AND SALTS THEREOFGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
CATHERINE ARABEYRE
PATRICIA MOLINER
SEBASTIEN ROY
DAMIEN SALLABERRY
SERGE PERARD
SABINE BOISNARD
France
France
France
France
France
France
2021-12-2263293070METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIAGenzyme CorporationProvisional Application Expired
José Bartelt-Hofer
France
2021-12-2163292124CRYSTALLINE FORMS OF (R)-1-(1-ACRYLOYLPIPERIDIN-3-YL)-4-AMINO-3-(4-PHENOXYPHENYL)-1H-IMIDAZO[4,5-C]PYRIDIN-2(3H)-ONE AND DERIVATIVES THEREOFGenzyme CorporationProvisional Application Expired
Tim Owens
Philippe Ochsenbein
Krista Diaz
United States
France
United States
2021-12-06PCTUS2021062078TREATMENT OF HEMOPHILIA WITH FITUSIRANGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
STACEY POLOSKEY
SHAUNA ANDERSSON
BAISONG MEI
YUE CUI
SAJIDA IQBAL
PRATIK R. BHAGUNDE
United States
United States
United States
United States
United States
United States
2021-12-06PCTUS2021062076TREATMENT OF HEMOPHILIA WITH FITUSIRANGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
STACEY POLOSKEY
SHAUNA ANDERSSON
BAISONG MEI
YUE CUI
SAJIDA IQBAL
PRATIK R. BHAGUNDE
United States
United States
United States
United States
United States
United States
2021-11-18PCTUS2021059946FLOW CYTOMETRY ATTENUATED REPORTER EXPRESSION (FLARE) MULTIPLE REPORTER SYSTEM AND METHODS OF USE THEREOFGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
VICTOR R. CAIRNS
JASON VITKO
DAVID RECZEK
United States
United States
United States
2021-11-0363275344TREATMENT OF HEMOPHILIA WITH FITUSIRANGenzyme CorporationProvisional Application Expired
Stacey Poloskey
Shauna Andersson
Pratik R. Bhagunde
Yue Cui
Sajida Iqbal
Baisong Mei
United States
United States
United States
United States
United States
United States
2021-10-2763272629TREATMENT OF HEMOPHILIA WITH FITUSIRANGenzyme CorporationProvisional Application Expired
Stacey Poloskey
Shauna Andersson
Pratik R. Bhagunde
Yue Cui
Sajida Iqbal
Baisong Mei
United States
United States
United States
United States
United States
United States
2021-09-30PCTUS2021052913HUMAN PAH EXPRESSION CASSETTE FOR TREATMENT OF PKU BY LIVER-DIRECTED GENE REPLACEMENT THERAPYGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
SIRKKA R.M. KYOSTIO-MOORE
United States
2021-09-17632452884-AMINO-3-(4-PHENOXYPHENYL)-1,3-DIHYDRO-2H-IMIDAZO[4,5-C]PYRIDIN-2-ONE DERIVATIVES AND SALTS THEREOFGenzyme CorporationProvisional Application Expired
Catherine Arabeyre
Patricia Moliner
Sabine Boisnard
Damien Sallaberry
Serge Perard
Sebastien Roy
France
France
France
France
France
France
2021-09-14PCTUS2021050216COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASEGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
KUNAL DESAI
ZHONG FANG
KEVIN GUERTIN
MARK MUNSON
JOHN ZIQI JIANG
SUNGTAEK LIM
JINYU LIU
VU HONG
United States
United States
United States
United States
United States
United States
United States
United States
2021-09-14PCTUS2021050210CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASEGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
KUNAL DESAI
ZHONG FANG
KEVIN GUERTIN
MARK MUNSON
JOHN ZIQI JIANG
SUNGTAEK LIM
VU HONG
United States
United States
United States
United States
United States
United States
United States
2021-09-0363240765INDOLE COMPOUNDS AND METHODS OF USEGenzyme CorporationProvisional Application Expired
Junkai Liao
Mark Munson
Sukanthini Thurairatnam
Bradford Hirth
Zhongli Gao
Gregory Hurlbut
David Borcherding
Matthieu Barrague
Timothy Alan Gillespy
Alexandre Gross
Andrew Good
Roy Vaz
Jinyu Liu
Yi Li
Markus Metz
Anatoly Ruvinsky
Claude Barberis
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
2021-09-0363240758INDOLE COMPOUNDS AND METHODS OF USEGenzyme CorporationProvisional Application Expired
Junkai Liao
Mark Munson
Sukanthini Thurairatnam
Bradford Hirth
Zhongli Gao
Gregory Hurlbut
David Borcherding
Matthieu Barrague
Timothy Alan Gillespy
Alexandre Gross
Thaddeus Nieduzak
Andrew Good
Roy Vaz
Jinyu Liu
Yi Li
Markus Metz
Anatoly Ruvinsky
Michael Kothe
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
2021-08-20PCTUS2021046958FGFR3 ANTIBODIES AND METHODS OF USEGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
YVES SABBAGH
YANGDE CHEN
WILLIAM BRONDYK
HUAWEI QIU
HYUNSUK CHO
RONNIE WEI
YU QIU
YANFENG ZHOU
CENDRINE LEMOINE
SUNGHAE PARK
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
2021-08-1617403592GLYCOENGINEERED ANTIBODY DRUG CONJUGATESGenzyme CorporationAmendment after notice of appealUS20220088214A1
Luis Z. Avila
Qun Zhou
United States
United States
LEE, HOI YAN NMN
2021-08-0417428505METHODS FOR TREATING SYMPTOMS AND DISORDERS ASSOCIATED WITH LYSOSOMAL STORAGE DISEASESGENZYME CORPORATIONPublications -- Issue Fee Payment VerifiedUS20220016092A1
Nigel Patrick Somerville CRAWFORD
Tanya Zaremba FISCHER
United States
United States
PIHONAK, SARAH
2021-07-2863226549DEUTERATED COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORSGenzyme CorporationProvisional Application Expired
John L. Kane JR.
Nellwyn A. Hagan
Maria A. Fitzgerald
United States
United States
United States
2021-07-1417375785METHODS AND COMPOSITIONS FOR TREATING A SERPINC1-ASSOCIATED DISORDERGenzyme CorporationFinal Rejection MailedUS20220017902A1
Akin Akinc
Benny Sorensen
Pushkal Garg
Gabriel Robbie
United States
United States
United States
United States
POLIAKOVA-GEORGAN, EKATERINA
2021-06-22PCTUS2021038445METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIAGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
BAISONG MEI
PRONABESH DASMAHAPATRA
QIFENG YU
SHAUNA ANDERSSON
United States
United States
United States
United States
2021-06-1863212473ANTI-TGF-BETA ANTIBODY FORMULATIONS AND THEIR USEGenzyme CorporationProvisional Application Expired
Ramil LATYPOV
Timothy MCCOY
Sanket PATKE
United States
United States
United States
2021-06-11PCTUS2021037111COMPOSITIONS AND METHODS FOR TREATING LATE-ONSET POMPE DISEASEGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
KRISTINA AN HAACK
CATHERINE WILSON
ALAA HAMED
PATRICK FINN
France
United States
United States
United States
2021-06-01PCTUS2021035264RABBIT ANTIBODIES TO HUMAN IMMUNOGLOBULINS GGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
RUIYIN CHU
United States
2021-05-1363188302PREDICTIVE BIOMARKERS FOR SECONDARY AUTOIMMUNITY AFTER LYMPHOCYTE DEPLETING THERAPYGenzyme CorporationProvisional Application Expired
Darren Phillip Baker
Emanuele de Rinaldis
Richa Hanamsagar
Evis Havari
Virginia Savova
Srinivas Shankara
United States
United States
United States
United States
United States
United States
2021-05-0763185786COMPOSITION AND METHODS FOR SANITIZATIONGenzyme CorporationProvisional Application Expired
Joseph P. Kutzko
Ryan F. Wollensak
United States
United States
2021-04-19PCTUS2021027981HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOFGENZYME CORPORATIONPCT - International Search Report Mailed to IB
STEPHEN MOORE
NINA C. LEKSA
MICHAEL STOREK
GRAHAM PARRY
United States
United States
United States
United States
KIM, HARRY CHONG HYUN
2021-04-16PCTUS2021027593RECEPTOR-INTERACTING PROTEIN KINASE INHIBITORS FOR TREATING CONDITIONS INVOLVING SYSTEMIC HYPERINFLAMMATORY RESPONSEGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
SABINE SCHNYDER
JOHN CAMINIS
PETER FLORIAN
MATIJA ZELIC
DIMITRY OFENGEIM
HERIBERT STAUDINGER
KEITH HARRIS
United States
United States
United States
United States
United States
United States
United States
2021-04-1463174900METHODS OF PERFUSION CULTURING A MAMMALIAN CELLGenzyme CorporationProvisional Application Expired
Shawn L. Barrett
Charles Budde
Daryl Powers
United States
United States
United States
2021-04-0717283433GENERATION OF IMPROVED HUMAN PAH FOR TREATMENT OF SEVERE PKU BY LIVER-DIRECTED GENE REPLACEMENT THERAPYGenzyme CorporationFinal Rejection MailedUS20210348135A1
Sirkka KYOSTIO-MOORE
Partha MANAVALAN
United States
United States
NICOL, ALEXANDER W
2021-03-2263164206SIZE EXCLUSION CHROMATOGRAPHY ANALYSIS OF EMPTY AND FULL AAV CAPSIDSGenzyme CorporationProvisional Application Expired
He MENG
United States
2021-03-0563157490COMPOSITIONS AND METHODS FOR TREATING LATE-ONSET POMPE DISEASEGenzyme CorporationProvisional Application Expired
Kristina AN HAACK
Patrick FINN
Alaa HAMED
Catherine WILSON
China
United States
United States
United States
2021-02-26PCTUS2021019958MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATIONGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
MARIE-PRISCILLE BRUN
FRANCIS DUFFIEUX
QUN ZHOU
HUAWEI QIU
SUNGHAE PARK
France
France
United States
United States
United States
2021-02-0963147629COMPOSITIONS AND METHODS FOR TREATING LATE-ONSET POMPE DISEASEGenzyme CorporationProvisional Application Expired
Kristina AN HAACK
Patrick FINN
Alaa HAMED
Catherine WILSON
China
United States
United States
United States
2021-01-29PCTUS2021015695MODIFIED ADENO-ASSOCIATED VIRAL CAPSID PROTEINS FOR OCULAR GENE THERAPY AND METHODS OF USE THEREOFGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
AMY FREDERICK
XIAOYING JIN
JENNIFER SULLIVAN
CATHERINE O'RIORDAN
LIN LIU
United States
United States
United States
United States
United States
2021-01-19PCTUS2021013883THERAPEUTIC TYROSINE KINASE INHIBITORS FOR RELAPSING MULTIPLE SCLEROSIS (RMS)GENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
MEEHYUNG CHO
ERIK WALLSTROEM
TIMOTHY J. TURNER
United States
United States
United States